Global Lactose Intolerance Treatment Market Research Report—Forecast till 2027
As per the market research future analysis, the Global Lactose Intolerance Treatment Market is expected to register a CAGR of 6.29% during the assessment period of 2020 to 2027 to reach USD 42,783.32 Million by 2027. Lactose intolerance is an illness in which patient can not digest sugar in milk that causes diarrhoea, gas and bloating after eating or drinking dairy products.
The global lactose intolerance treatment market is expected to witness a healthy market growth during the review period. The lactose intolerance illness is of four main types of as primary lactase deficiency, secondary lactase deficiency, congenital lactase deficiency, and developmental lactase deficiency. According to the journal of health, population, and Nutrition published in 2017, the lactose intolerance incidences was higher in IBS-D patients as compared to healthy people.
Global Lactose Intolerance Treatment Market has been classified into Type, Treatment, Form, and End User.
Based on the type segment, Global Lactose Intolerance Treatment Market has been categorized into primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance. Primary lactose intolerance dominated the market in 2019. Primary lactose intolerance has a high prevalence rate as compared to others.
In terms of treatment the global market has been classified into food supplements, enzyme lactase supplements, probiotics. The food supplements segment is expected to dominate the market due to the largest market share in 2019. The growing adoption of Lactose-free products is fuelling the market growth of this segment.
By form segment, the market has been divided into powder, liquid, tablet. The powder segment held the largest market in 2019. Based on end user segment the global lactose intolerance treatment market has been categorized into homecare, hospitals and clinics, and others. The homecare segment is expected to lead the market during the forecast period owing to the largest share with a CAGR of 6.04% in 2019.
Geographically, the Global Lactose Intolerance Treatment Market has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to command the market during the study period owing to the largest market share in 2019. The region has further been categorized into North America and Latin America with North America is further divided into the US and Canada. The regional market growth is driven by the increasing prevalence of lactose intolerance and product innovation.
The Europe is expected to register second largest market of global lactose intolerance followed by Asia Pacific. The regional market is attributed to the existence of favourable government initiatives, research and development activities, and business expansions by major players.
The lactose intolerance treatment market in Asia-Pacific is anticipated to register the highest market growth expansion during the study period owing to rising healthcare expenditure, distribution of chilled dairy products in China, India, and Australia, and increasing population suffering from lactose intolerance.
The Key Players in the Global Lactose Intolerance Treatment Market are Abbott (US)., Nestlé (Switzerland), Cargill, Incorporated (US), Dean Foods (US), and Johnson & Johnson Services, Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.